Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.4K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

29.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
29.5K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

2.4K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.4K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.1K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Easy and versatile preparation of <sup>68</sup>Ga- and Al<sup>18</sup>F-labelled arylphosphonium salts from a common precursor: stability and preliminary in vivo PET/CT evaluation.

EJNMMI radiopharmacy and chemistry·2026
Same author

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Stem cell reports·2026
Same author

An alternate receptor for adeno-associated viruses.

Cell·2025
Same author

Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

Unlocking the in vivo therapeutic potential of radiation-activated photodynamic therapy for locally advanced rectal cancer with lymph node involvement.

EBioMedicine·2025
Same author

Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.

The New England journal of medicine·2025

Related Experiment Video

Updated: Nov 3, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.1K

Will cell reprogramming resolve the embryonic stem cell controversy? A narrative review.

Carl Power1, John E J Rasko

  • 1Centenary Institute, University of Sydney, and the Royal Prince Alfred Hospital, Sydney, Australia.

Annals of Internal Medicine
|July 20, 2011
PubMed
Summary

New induced pluripotent stem cells offer medical promise but raise complex ethical concerns. Cell reprogramming may complicate, rather than solve, the ongoing stem cell controversy.

More Related Videos

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.5K
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

6.8K

Related Experiment Videos

Last Updated: Nov 3, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.1K
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.5K
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

6.8K

Area of Science:

  • Biotechnology and Regenerative Medicine
  • Stem Cell Biology
  • Bioethics

Background:

  • Recent advances in laboratory techniques enable the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs).
  • iPSCs possess similar potential to embryonic stem cells but avoid associated ethical controversies.
  • The transformative potential of iPSCs in regenerative and reproductive medicine is significant.

Purpose of the Study:

  • To examine the impact of cell reprogramming on regenerative and reproductive medicine.
  • To highlight the medical, moral, and political challenges associated with iPSCs.
  • To argue that iPSCs present greater ethical complexities than commonly perceived.

Main Methods:

  • Review of laboratory techniques for cell reprogramming.
  • Analysis of the medical, ethical, and political implications of induced pluripotent stem cells.
  • Comparative assessment of iPSCs versus embryonic stem cells in ethical and medical contexts.

Main Results:

  • Induced pluripotent stem cells (iPSCs) offer substantial medical promise, potentially exceeding that of embryonic stem cells.
  • Despite initial perceptions, iPSCs introduce novel ethical considerations.
  • Cell reprogramming is poised to significantly alter regenerative and reproductive medicine.

Conclusions:

  • Cell reprogramming technology, while promising, presents significant ethical challenges.
  • The widespread adoption of iPSCs may further complicate, rather than resolve, the broader stem cell debate.
  • A thorough examination of the medical, moral, and political landscape is crucial for navigating the future of iPSC technology.